Company · CIK 1708688
InflaRx N.V.
| CIK | 1708688 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | P7 |
| Business address | Germany |
| Listed | IFRX (Nasdaq) |
| First annual or quarterly report | 2018-03-29 |
Offerings
5 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-298039 | 2026-08-06 | 2026-08-14 | 3 | |
| 333-273058 | 2023-06-30 | 2026-05-07 | 8 | |
| 333-239759 | 2020-07-08 | 2023-04-13 | 7 | |
| 333-224596 | 2018-05-02 | 2018-05-07 | 3 | |
| 333-220962 | 2017-10-13 | 2017-11-08 | 7 |
Filings
30| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-08-14 | 424B5Shelf takedown | 333-298039 | 0001140361-26-033149 |
| 2026-08-12 | EFFECTDeclared effective | 333-298039 | 9999999995-26-002649 |
| 2026-08-06 | F-3Shelf registered | 333-298039 | 0001140361-26-031554 |
| 2026-05-07 | 424B5Shelf takedown | 333-273058 | 0001140361-26-019440 |
| 2026-05-06 | 424B5Shelf takedown | 333-273058 | 0001140361-26-019288 |
| 2025-02-18 | 424B5Shelf takedown | 333-273058 | 0001140361-25-004927 |
| 2025-02-13 | 424B5Shelf takedown | 333-273058 | 0001140361-25-004369 |
| 2024-06-28 | 424B5Shelf takedown | 333-273058 | 0001140361-24-031785 |
| 2023-07-12 | 424B5Shelf takedown | 333-273058 | 0001140361-23-034194 |
| 2023-07-11 | EFFECTDeclared effective | 333-273058 | 9999999995-23-002064 |
| 2023-06-30 | F-3Shelf registered | 333-273058 | 0001140361-23-032443 |
| 2023-04-13 | 424B5Shelf takedown | 333-239759 | 0001140361-23-018123 |
| 2023-04-11 | 424B5Shelf takedown | 333-239759 | 0001140361-23-017771 |
| 2021-02-26 | 424B5Shelf takedown | 333-239759 | 0001140361-21-006442 |
| 2021-02-24 | 424B5Shelf takedown | 333-239759 | 0001140361-21-006045 |
| 2020-07-20 | 424B5Shelf takedown | 333-239759 | 0001140361-20-016369 |
| 2020-07-17 | EFFECTDeclared effective | 333-239759 | 9999999995-20-001851 |
| 2020-07-08 | F-3Shelf registered | 333-239759 | 0001140361-20-015637 |
| 2018-05-07 | 424B4Final prospectus | 333-224596 | 0000950103-18-005944 |
| 2018-05-03 | EFFECTDeclared effective | 333-224596 | 9999999995-18-001136 |
| 2018-05-02 | F-1Registration filed | 333-224596 | 0000950103-18-005705 |
| 2018-04-23 | DRSDraft made public | 377-02034 | 0000950103-18-005047 |
| 2017-11-08 | 424B4Final prospectus | 333-220962 | 0001193125-17-337427 |
| 2017-11-07 | EFFECTDeclared effective | 333-220962 | 9999999995-17-002900 |
| 2017-11-07 | F-1/AAmendment | 333-220962 | 0000950103-17-010902 |
| 2017-10-31 | F-1/AAmendment | 333-220962 | 0001193125-17-327347 |
| 2017-10-30 | F-1/AAmendment | 333-220962 | 0001193125-17-323823 |
| 2017-10-26 | F-1/AAmendment | 333-220962 | 0000950103-17-010266 |
| 2017-10-13 | F-1Registration filed | 333-220962 | 0000950103-17-009967 |
| 2017-06-23 | DRSDraft made public | 377-01604 | 0000950103-17-006023 |